UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma

Annals of oncology, 2013-03, Vol.24 (3), p.577-585

2013

Volltextzugriff (PDF)

Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry

Oncogene, 2011-04, Vol.30 (15), p.1744-1752

2011

Volltextzugriff (PDF)

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

Annals of oncology, 2013-10, Vol.24 (10), p.2601-2606

2013

Volltextzugriff (PDF)

Treatment Receipt and Outcomes among Lung Cancer Patients with Depression

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-01, Vol.26 (1), p.25-31

2014

Volltextzugriff (PDF)

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

The New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301

2018

Volltextzugriff (PDF)

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

The lancet oncology, 2015-03, Vol.16 (3), p.257-265

2015

Volltextzugriff (PDF)

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial

Journal of clinical oncology, 2015-03, Vol.33 (9), p.1000-1007

2015

Volltextzugriff (PDF)

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

Molecular cancer, 2011-04, Vol.10 (1), p.35-35, Article 35

2011

Volltextzugriff (PDF)

Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development

Digestive diseases and sciences, 2015-08, Vol.60 (8), p.2373-2383

2015

Volltextzugriff (PDF)

Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2019-08, Vol.24 (8), p.1095-1102

2019

Volltextzugriff (PDF)

Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2052-2059

2011

Volltextzugriff (PDF)

Antiproliferative and Proapoptotic Effects of Astemizole on Cervical Cancer Cells

International journal of gynecological cancer, 2014-06, Vol.24 (5), p.824-828

2014

Volltextzugriff (PDF)

Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC

Tumor biology, 2015-08, Vol.36 (8), p.6149-6158

2015

Volltextzugriff (PDF)

Association of patient characteristics with chemotherapy receipt among depressed and non-depressed patients with non-small cell lung cancer

Psycho-oncology (Chichester, England), 2014-11, Vol.23 (11), p.1318-1322

2014

Volltextzugriff (PDF)

Systemic Issues in Small Cell Lung Cancer

Current problems in cancer, 2012-05, Vol.36 (3), p.131-155

2012

Volltextzugriff (PDF)

Probable Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma: A Case Report of a Diagnostic Challenge

Curēus (Palo Alto, CA), 2023-08

2023

Volltextzugriff (PDF)

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

The lancet oncology, 2014-02, Vol.15 (2), p.191-200

2014

Volltextzugriff (PDF)

Young Male with Fanconi Anemia and EGFR-Mutant Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2014-11, Vol.9 (11), p.e83-e85

2014

Volltextzugriff (PDF)

From platinum compounds to targeted therapies in advanced thoracic malignancies

Anticancer research, 2014-01, Vol.34 (1), p.477-482

2014

Volltextzugriff (PDF)

A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study

Clinical cancer research, 2014-11, Vol.20 (21), p.5392-5402

2014

Volltextzugriff (PDF)

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2014-10, Vol.9 (10), p.e75-e78

2014

Volltextzugriff (PDF)

Targeted therapies Importance of patient selection for EGFR TKIs in lung cancer

Nature reviews. Clinical oncology, 2010-07, Vol.7 (7), p.360-362

2010

Volltextzugriff (PDF)

Bevacizumab Maintenance in Patients with Advanced Non–Small-Cell Lung Cancer, Clinical Patterns, and Outcomes in the Eastern Cooperative Oncology Group 4599 Study: Results of An Exploratory Analysis

Journal of thoracic oncology, 2012-11, Vol.7 (11), p.1707-1712

2012

Volltextzugriff (PDF)

Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Sorafenib

Clinical cancer research, 2011-03, Vol.17 (5), p.1190-1199

2011

Volltextzugriff (PDF)

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Lung cancer (Amsterdam, Netherlands), 2017-09, Vol.111, p.108-115

2017

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Humans
(23)
Male
(16)
Aged
(14)
Female
(13)
Lung Neoplasms - Drug Therapy
(12)
Middle Aged
(11)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(10)
Antineoplastic Agents - Therapeutic Use
(8)
Treatment Outcome
(8)
Adult
(7)
Lung Cancer
(7)
Lung Neoplasms - Genetics
(7)
Mutation
(7)
Carcinoma, Non-Small-Cell Lung - Genetics
(6)
Lung Neoplasms - Pathology
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Apoptosis
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma

Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

Treatment Receipt and Outcomes among Lung Cancer Patients with Depression

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development

Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer

Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

Antiproliferative and Proapoptotic Effects of Astemizole on Cervical Cancer Cells

Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC

Association of patient characteristics with chemotherapy receipt among depressed and non-depressed patients with non-small cell lung cancer

Systemic Issues in Small Cell Lung Cancer

Probable Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma: A Case Report of a Diagnostic Challenge

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

Young Male with Fanconi Anemia and EGFR-Mutant Non–Small-Cell Lung Cancer

From platinum compounds to targeted therapies in advanced thoracic malignancies

A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

Targeted therapies Importance of patient selection for EGFR TKIs in lung cancer

Bevacizumab Maintenance in Patients with Advanced Non–Small-Cell Lung Cancer, Clinical Patterns, and Outcomes in the Eastern Cooperative Oncology Group 4599 Study: Results of An Exploratory Analysis

Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Sorafenib

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Aktive Filter

Suchergebnisse filtern